| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000019252 |
| Receipt No. | R000019812 |
| Official scientific title of the study | Investigation of the secretion of glucagon for glucose intolerance |
| Date of disclosure of the study information | 2015/11/01 |
| Last modified on | 2018/10/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Investigation of the secretion of glucagon for glucose intolerance | |
| Title of the study (Brief title) | Investigation of the secretion of glucagon for glucose intolerance | |
| Region |
|
|
| Condition | |||
| Condition | Normal glucose tolerance (NGT), Impaired glucose tolerance(IGT), Type 2 diabetes (T2DM) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The response of glucagon wii be examined during the oral glucose tolelrance test and the hyperglycemic clamp in Japanease subjects with NGT, IGT and T2DM. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of the area under the glucagon curve during hyperglycemic clamp among three groups (NGT,IGT and T2DM)
|
| Key secondary outcomes | Comparison of the area under the insulin curve during hyperglycemic clamp among three groups (NGT,IGT and T2DM) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Capable to be inserted cathter at three different site at both arm
2)The level of fasting plasma glucose less than 130 mg/dl |
|||
| Key exclusion criteria | 1)Type 1 DM
2)Pancreatic diabetes 3)Medical history of gastrointestinal tract surgery 4)Having insulin antibody(>10%) 5)Treatment with any long-acting insulin 6)Treatment with steroid 7)Impaired liver function, defined as alanine aminotransferase >2 times upper limit of normal(HBC or HCV infection) 8) Impaired renal function defined as eGFR <60ml/min 9) Severe cardiac dysfunction (> NYHA 3) 10)Cancer and medical history of cancer 11)Pregnancy or breast feeding 12)Known or suspected abuse of alcohol, narcotics or illicit drugs 13)Mental retardation or dementia or other inappropriate persons judged by investigators |
|||
| Target sample size | 105 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko Sakaguchi |
| Organization | Kobe university school of medicine |
| Division name | Diabetes and Endocrinoplogy |
| Address | 7-5-1,Kusunoki-Cho, Chuo-Ku, Kobe |
| TEL | 078-382-5861 |
| kzhskskgc@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiko Sakaguchi |
| Organization | Kobe university school of medicine |
| Division name | Diabetes and Endocrinoplogy |
| Address | 7-5-1,Kusunoki-Cho, Chuo-Ku, Kobe |
| TEL | 078-382-5861 |
| Homepage URL | |
| kzhskskgc@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe university school of medicine, Diabetes and Endocrinoplogy |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Donation |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019812 |